iPro2 Professional CGM Archive

Proving the Economic Benefits of Professional CGM

Our economic analysis of professional CGM using real-world data was published in the Journal of Medical Economics. With this analysis, Medtronic Diabetes is the first to demonstrate the significant clinical and health economic benefits of professional CGM products – such as iPro™2 – for people living with type 2 diabetes, and healthcare systems. Prior

Developing A New Tool with Fitbit for Simplified Type 2 Diabetes Management

Today we announced a partnership with Fitbit to integrate health and activity data into new CGM solutions for simplified type 2 diabetes management. This partnership brings together our sophisticated medical technology with the convenience of automatic activity tracking from Fitbit. Together we can provide meaningful insights into how exercise impacts glucose levels for more

Medtronic Turning Point Program: Helping Healthcare Systems Manage At-Risk Diabetes Patients

The estimated medical costs of managing people diagnosed with diabetes in the United States is $176 billion and community hospitals carry more than 40% of that financial burden.[1] People with diabetes – particularly those with lower socioeconomic status or limited access to primary care – frequently seek care in hospital emergency departments (ED).[2],[3] When